Pins matching place:Vevey

Nestlé's first-half organic growth was 2.9%, almost all of it from pricing with real internal growth of just 0.2%, while reported sales fell 1.8% to CHF 44.2 billion on the strong franc. CEO Laurent Freixe kept 2025 guidance, including an underlying trading margin at or above 16.0%.

Nestlé's board dismissed Laurent Freixe with immediate effect after an investigation found an undisclosed romantic relationship with a direct subordinate, one year into his tenure. Nespresso chief Philipp Navratil, a Nestlé lifer who joined as an internal auditor in 2001, took over as CEO.

Former Inditex boss Pablo Isla took over as Nestlé's chairman on 1 October 2025, six months earlier than planned, after Paul Bulcke chose to step down in the wake of the CEO's dismissal. Dick Boer became Lead Independent Director and Vice Chairman.

In Philipp Navratil's first results as CEO, Nestlé's third-quarter organic growth rose to 4.3% with volumes (RIG) back up 1.5%, and it raised its cost-savings target to CHF 3.0 billion by 2027, including about 16,000 job cuts over two years. The shares closed 9.3% higher.

New CEO Philipp Navratil set out a global headcount reduction of about 16,000 - some 12,000 white-collar roles and 4,000 in manufacturing and supply chain - and raised Nestlé's Fuel for Growth savings target to CHF 3.0 billion by the end of 2027. The shares jumped more than 8%.

After tracing the toxin cereulide to arachidonic acid (ARA) oil from a global supplier, Nestlé began recalling SMA, BEBA, NAN, Alfamino and Guigoz batches country by country from 5 January 2026, in more than 60 countries.

Nestlé grew 3.5% organically in 2025 on sales of CHF 89.5 billion, proposed a dividend of CHF 3.10 a share, up 5 centimes, and set out a focus on four businesses: Coffee, Petcare, Nutrition and Food & Snacks. It guided to around 3% to 4% organic growth in 2026.

Nestlé agreed to sell Blue Bottle Coffee, bought in 2017, to Centurium Capital, the biggest shareholder of China's Luckin Coffee, with the deal expected to close in the first half of 2026. The sale covers Blue Bottle's more than 100 cafes and most of its packaged-coffee business; Nestlé keeps the Blue Bottle Nespresso pods.

Nestlé grew 3.5% organically in the first quarter, led by coffee, even though its infant formula recall cut about 0.9 points off growth; reported sales fell 5.7% to CHF 21.3 billion on the strong franc. It kept its 2026 guidance.

Nestlé's first-half organic growth reached 3.6% and volumes (RIG) improved to 1.8% in the second quarter, but net profit fell 31.4% to CHF 3.5 billion on restructuring and a CHF 1.3 billion write-down of businesses it is selling. It kept its 3% to 4% growth guidance for 2026.

Nestlé will put S.Pellegrino, Perrier, Acqua Panna, Nestlé Pure Life and its other waters and premium beverages into Peranel, a 50:50 joint venture with Platinum Equity valued at EUR 4.9 billion. Nestlé expects about EUR 3.0 billion in cash at closing, due in the first half of 2027.

Nestlé agreed to sell its mainstream vitamins business - Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride and Sisu, with its US private-label supplements and their plants - to Yellow Wood Partners for $1.0 billion. The business had $1.2 billion of sales in 2025; Nestlé keeps premium brands such as Solgar and Pure Encapsulations.

Nestlé reported CHF 22.756 billion Q3 sales and 4.0% organic growth. Nine-month reported sales were essentially flat at CHF 65.865 billion, with full-year guidance maintained.

Nestlé publishes its 2026 full-year results, the test of its 3% to 4% organic growth guidance and CHF 9 billion free-cash-flow target, a year after the results day on which it proposed its CHF 3.10 dividend for 2025.

Expected completion of the deal that moves S.Pellegrino, Perrier, Acqua Panna and Nestlé's other waters into Peranel, a 50:50 joint venture with Platinum Equity, paying Nestlé about EUR 3.0 billion (CHF 2.8 billion) in cash. Closing still needs employee consultations and regulatory approvals.

Expected completion of Yellow Wood Partners' $1.0 billion purchase of Nature's Bounty, Nuun, Osteo Bi-Flex, Ester-C, Gard, Puritan's Pride and Sisu from Nestlé, pending regulatory approvals. The carved-out business, with $1.2 billion of 2025 sales, will run as a standalone company.

Nestlé aims to finish cutting about 16,000 jobs and reach CHF 3.0 billion of Fuel for Growth cost savings by the end of 2027. By mid-2026 it reported CHF 1.7 billion of savings delivered.